Answers are grounded in this paper and cite their sources.
The prevalence and psychopathologic features of psychiatric adverse events (PAE) in 517 patients taking levetiracetam (LEV) were investigated. Fifty-three (10.1%) patients developed PAE. A significant association was found with previous psychiatric history, history of febrile convulsions, and history of status epilepticus, whereas lamotrigine co-therapy had a protective effect. PAE were not related to the titration schedule of LEV, and certain patients seem to be biologically more vulnerable.
No takes yet. Share an insight, caveat, or question.
Mula et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: